Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Dare Bioscience (DARE) Leases (2020 - 2025)

Dare Bioscience's Leases history spans 6 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Leases changed N/A year-over-year to $1.1 million; the TTM value through Dec 2025 reached $1.1 million, changed N/A, while the annual FY2025 figure was $1.1 million, N/A changed from the prior year.
  • Leases reached $1.1 million in Q4 2025 per DARE's latest filing, down from $2.2 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $2.2 million in Q3 2025 to a low of $216700.0 in Q4 2021.
  • Average Leases over 5 years is $1.2 million, with a median of $1.2 million recorded in 2023.
  • Peak YoY movement for Leases: surged 188.18% in 2023, then crashed 33.9% in 2025.
  • A 5-year view of Leases shows it stood at $216700.0 in 2021, then soared by 111.32% to $457925.0 in 2022, then soared by 188.18% to $1.3 million in 2023, then rose by 0.62% to $1.3 million in 2024, then fell by 17.34% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for DARE's Leases are $1.1 million (Q4 2025), $2.2 million (Q3 2025), and $955651.0 (Q2 2025).